- Previous Rank486
- Revenues ($M)5,460
- Revenue Percent Change7.1%
- Profits ($M)356
- Profits Percent Change57.3%
- Market Value (as of March 31, 2015)8,358
The global contract-research firm conducts clinical trials and other activities for pharmaceutical companies.
Company Info
CEO | Thomas H. Pike |
Industry | Health Care: Pharmacy and Other Services |
Sector | Health Care |
HQ Location | Durham, NC |
Website | http://www.quintiles.com |
Years on List | 2 |
Key Financials (last fiscal year)
$ millions | % change | |
---|---|---|
Revenues ($M) | 5,460 | 7.1% |
Profits ($M) | 356 | 57.3% |
Total Stockholder Equity | -704 | - |
Employees | 32,600 | - |
Market Value (as of March 31, 2015) | 8,358 | - |
Profit Ratios
Profit as % of Revenues | 6.5% |
Profits as % of Assets | 10.8% |
Profits as % of Stockholder Equity | - |
Earnings Per Share (last fiscal year)
Earnings Per Share ($) | 2.72 |
EPS % Change (from 2013) | 53.7% |
EPS % Change (5 year annual rate) | - |
EPS % Change (10 year annual rate) | - |
Total Return
Total Return to Investors (2014) | 27% |
Total Return to Investors (5 year, annualized) | - |
Total Return to Investors (10 year, annualized) | - |